← FDA Drug Approvals (Drugs@FDA)

XERAVA

NDA · New Drug Application · Sponsor: TETRAPHASE PHARMS · Approved 2018-08-27

Drug application

FDA Application #

NDA211109

Application type

New Drug Application

Brand name

XERAVA

Generic name

ERAVACYCLINE

Active ingredients

ERAVACYCLINE DIHYDROCHLORIDE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

TETRAPHASE PHARMS

Manufacturer

Tetraphase Pharmaceuticals, Inc.

First approval

2018-08-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown